Burden and costs of migraine in a Swedish defined patient population – a questionnaire-based study

Background Migraineis a disabling, chronic neurological disease leading to severe headache episodes affecting 13.2% of the Swedish population. Migraineleads to an extensive socio-economic burden in terms of healthcare costs, reduced workforce and quality of life (QoL) but studies of the health-economicconsequences in a Swedish context are lacking. The objective of this study is to map the health-economicconsequences of migrainein a defined patient population in terms of healthcare consumption, production loss and QoL in Sweden.